BR0112355A - Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana - Google Patents

Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana

Info

Publication number
BR0112355A
BR0112355A BR0112355-6A BR0112355A BR0112355A BR 0112355 A BR0112355 A BR 0112355A BR 0112355 A BR0112355 A BR 0112355A BR 0112355 A BR0112355 A BR 0112355A
Authority
BR
Brazil
Prior art keywords
egf
human skin
prevention
tyrosine kinase
kinase protein
Prior art date
Application number
BR0112355-6A
Other languages
English (en)
Inventor
John J Voorhees
Gary J Fisher
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of BR0112355A publication Critical patent/BR0112355A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

"USO DE INIBIDORES DA PROTEìNA EGF-R TIROSINA CINASE PARA A PREVENçãO DO FOTOENVELHECIMENTO DA PELE HUMANA". Fotoenvelhecimento de pele humana, tal como evidenciado pela presença aumentada de metaloproteinase matriz, após exposição à radiação UV, é prevenida pelo pré-tratamento da pele com um inibidor de receptor de fator de crescimento epidérmico (EGF-R) antes da exposição. Tais inibidores são, de preferência, naturais, um exemplo dos quais é geniesteína. Composições usadas para tais propósitos incluem, de preferência, um inibidor de EGF-R, bem como outro inibidor de MMP, tal como um retinóide.
BR0112355-6A 2000-06-26 2001-06-26 Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana BR0112355A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21394000P 2000-06-26 2000-06-26
PCT/US2001/041154 WO2002000183A2 (en) 2000-06-26 2001-06-26 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin

Publications (1)

Publication Number Publication Date
BR0112355A true BR0112355A (pt) 2005-04-19

Family

ID=22797119

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112355-6A BR0112355A (pt) 2000-06-26 2001-06-26 Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana

Country Status (8)

Country Link
US (2) US20020012641A1 (pt)
EP (1) EP1294349A2 (pt)
JP (1) JP2004504276A (pt)
AU (1) AU2001272028A1 (pt)
BR (1) BR0112355A (pt)
CA (1) CA2414406A1 (pt)
MX (1) MXPA03000089A (pt)
WO (1) WO2002000183A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516873A (en) * 2001-02-12 2003-11-28 Warner Lambert Co Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
AU2003250701A1 (en) * 2002-07-31 2004-02-16 Wayne R. Danter Protein tyrosine kinase inhibitors
WO2004033446A1 (en) * 2002-10-09 2004-04-22 Danter Wayne R Protein tyrosine kinase inhibitors
JP2005263645A (ja) * 2004-03-16 2005-09-29 Shiseido Co Ltd 炎症を抑制する方法及び組成物
US20080119530A1 (en) * 2006-09-29 2008-05-22 Hansen Laura A Method for treatment and prevention of ultraviolet light induced skin pathologies
JP5746807B2 (ja) * 2006-12-28 2015-07-08 アルロン・ジャパン株式会社 皮膚用化粧品の組成物
US8034815B2 (en) 2007-01-11 2011-10-11 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
US20080269339A1 (en) * 2007-04-26 2008-10-30 Thomas Robert Sutter Combined use of egf pathway inhibitors and differentiation promoting compounds
JP2011500669A (ja) * 2007-10-17 2011-01-06 ニュートゥリー カンパニー リミテッド パンドラチン誘導体またはこれを含有するケンフェリアパンドラタ抽出物の新規な用途
JP6309184B2 (ja) * 2007-11-15 2018-04-11 ザ ジェネラル ホスピタル コーポレイション 皮膚損傷の減少のための方法、及び組成物
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
AU2009232715B2 (en) * 2008-03-31 2015-07-09 Shiseido Company Ltd. Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
WO2009122540A1 (ja) * 2008-03-31 2009-10-08 株式会社資生堂 しわを防止または改善するための経口、注射、皮膚外用剤および美容方法
EP2318406B1 (en) 2008-07-17 2016-01-27 Critical Outcome Technologies, Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
KR102200014B1 (ko) * 2013-05-06 2021-01-08 (주)아모레퍼시픽 쿠메스트롤을 포함하는 콩 추출물을 유효성분으로 포함하는 갱년기 증상의 예방 및 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
CA2265630A1 (en) * 1996-09-13 1998-03-19 Gerald Mcmahon Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
IL131543A (en) * 1997-02-25 2005-08-31 Univ Michigan Cosmetic methods and compositions for preventing and treating chronological aging in human skin
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
US6258820B1 (en) * 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
JP2001039849A (ja) * 1999-07-27 2001-02-13 Shiseido Co Ltd コラーゲン産生促進剤

Also Published As

Publication number Publication date
US20050281764A1 (en) 2005-12-22
WO2002000183A2 (en) 2002-01-03
CA2414406A1 (en) 2002-01-03
US20020012641A1 (en) 2002-01-31
EP1294349A2 (en) 2003-03-26
AU2001272028A1 (en) 2002-01-08
JP2004504276A (ja) 2004-02-12
MXPA03000089A (es) 2004-09-13
WO2002000183A3 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
BR0112355A (pt) Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana
BR0108347A (pt) Composição de cosmético
ES2539430T3 (es) Derivados de metastina y uso de los mismos
EA200300105A1 (ru) Нестероидные ингибиторы воспалений
BR0210593A (pt) polinucleotìdeos de defensina e métodos de uso
NO982907D0 (no) Tyrosinderivater som <alfa>-v-integrininhibitorer
DE1066580T1 (de) Portfoliooptimierung mittels wiederabgetasteter effizienter lösungsmengen
CY2014034I2 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
NO20011575L (no) Substituerte 3-cyanokinoliner som proteintyrosin-kinase- inhibitorer
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
ATE495736T1 (de) Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel
BR0011172A (pt) Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2
CR8255A (es) Tienopirazoles
FI972492A (fi) Imidatsolijohdoksia proteiinikinaasien, erityisesti EGF-R-tyrosiinikinaasin, inhibiittoreina
ATE406156T1 (de) Ajulemische säure zur krebsbehandlung
DE60028010D1 (de) Verminderung des haarwuchses
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
BR9609920A (pt) Uso de griseofulvina para inibir o crescimento de cânceres
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
BR0311318A (pt) Inibidores de peptìdeo desformilase
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
GT199700104BA (es) Procedimientos e intermedios para preparar derivados de cromanol sustituidos
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/49 (2006.01), A61Q 19/08 (2006.01)